Cargando…
Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma
PRECIS: At 1-year postoperative follow-up, concurrent placement of a dexamethasone intravitreal implant and glaucoma drainage device effectively controlled intraocular pressure (IOP) and inflammation in eyes with uveitic glaucoma with no changes in systemic immunomodulatory therapy. PURPOSE: The pur...
Autores principales: | Nguyen, Tran, Kim, Han, Mielke, Christy, Momont, Anna C., Brandt, James D., Liu, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147398/ https://www.ncbi.nlm.nih.gov/pubmed/31990825 http://dx.doi.org/10.1097/IJG.0000000000001454 |
Ejemplares similares
-
Risk factors for Baerveldt glaucoma drainage implantation for uveitic glaucoma
por: Manako, Kiyofumi, et al.
Publicado: (2023) -
Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature
por: Ramdas, Wishal D., et al.
Publicado: (2018) -
Uveitic Glaucoma
por: Amini, Heydar, et al.
Publicado: (2009) -
Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
por: Noor, Nina Asrini, et al.
Publicado: (2017) -
Pediatric Uveitic Glaucoma
por: Kaur, Savleen, et al.
Publicado: (2013)